Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis



Rating:

Share or cite this content

Citations should be made in the following way:
K. Knudsen (Bergen, Norway), S. Lehmann (Bergen, Norway), P. Hiemstra (Leiden, Netherlands), R. Nielsen (Bergen, Norway), T. Eagan (Bergen, Norway). The pulmonary microbiome and immunological activity in IPF patients.. 3386

Member's Comments

No comment yet.

Related content which might interest you: The lower airways microbiome in patients with IPF and COPD Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 The pulmonary microbiome in sarcoidosis is similar to other parenchymal lung diseases Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018 The gut microbiota state in patients with pulmonary tuberculosis. Source: Virtual Congress 2021 – Immunological and molecular characterisation of tuberculosis disease and infection Year: 2021 The pulmonary bacterial and fungal microbiota in sarcoidosis patients. Source: Virtual Congress 2021 – Better understanding of sarcoidosis: new keys Year: 2021 History of pulmonary tuberculosis was associated with lung microbiome change in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD Year: 2020 Pulmonary and systemic cellular immune response network in patients with mild-moderate COPD Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017 The microbiome in IPF Source: International Congress 2014 – ERS/NEJM joint lunchtime session "The changing landscape of idiopathic pulmonary fibrosis (IPF)" Year: 2014 Relationships between angiogenic activity of sera from interstitial lung disease (ILD) patients and lung function tests Source: Eur Respir J 2002; 20: Suppl. 38, 106s Year: 2002 Can clinical data predict rapid decline of lung function in idiopathic pulmonary fibrosis (IPF) patients? Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017 Overlapping biologic exacerbation clusters in asthma and chronic obstructive pulmonary disease have distinct sputum mediator and microbiome profiles Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 The markers of inflammatory process activity and fybrogenesis activity in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 Analysis of the lung microbiota in healthy dogs and in canine idiopathic pulmonary fibrosis, a possible spontaneous model for human IPF. Source: International Congress 2018 – Pulmonary fibrosis: from models to patients Year: 2018 The contribution of infection and the respiratory microbiome in acute exacerbations of idiopathic pulmonary fibrosis Source: Eur Respir Rev, 28 (152) 190045; 10.1183/16000617.0045-2019 Year: 2019 COPD as a lung disease with heterogeneous systemic inflammatory consequences: clinical impact Source: Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD Year: 2011 The correlation between lung sound distribution and pulmonary function in COPD patients is influenced by emphysematous lesions Source: International Congress 2014 – Multidimensional analysis of respiratory problems Year: 2014 Clinical characteristics of postoperative pulmonary infection in lung cancer patients with obstructive pulmonary disease: the trend of microorganisms in bronchial colonization Source: Annual Congress 2006 - Contemporary issues in thoracic surgical oncology Year: 2006 The microbiome in interstitial lung disease Source: Lung Science Conference 2015 Year: 2015 Angiogenic activity of sera from patients with various types of pulmonary fibrosis in relation to pulmonary functions Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation Year: 2009 Evaluation of specific immune complexes in patients with pulmonary sarcoidosis. Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management Year: 2018 Analysis of pulmonary function in patients with idiopathic pulmonary fibrosis (IPF): how stable is stable IPF? Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis Year: 2009